Interleukin-10 induces apoptosis in developing mast cells and macrophages

Journal of Leukocyte Biology

Volumn 80, Issue 3, 2006, Pages 581-589

  Bailey, Daniel P ^a   Kashyap, Mohit ^a   Bouton, L Andrew ^a   Murray, Peter J ^b   Ryan, John J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Caspase 3; Hematopoietic; Immune homeostasis; Inflammation; Mitochondrial membrane potential; Stat3

Indexed keywords

CASPASE 3; GROWTH FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 3; PROTEIN BCL 2; STAT3 PROTEIN; STEM CELL FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; HEMATOPOIETIC STEM CELL; INFLAMMATION; MACROPHAGE; MAST CELL; MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL SURVIVAL; INTERLEUKIN-10; INTERLEUKIN-3; MACROPHAGES; MAST CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-KIT; STAT3 TRANSCRIPTION FACTOR; STEM CELL FACTOR;

MUS MUSCULUS;

EID: 33751544158     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0405201     Document Type: Article

References (58)

1. Feger, F., Varadarajalou, S., Gao, Z., Abraham, S. N., Arock, M. (2002) The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol. 23, 151-158.
2. Secor, V. H., Secor, W. E., Gutekunst, C-A., Brown, M. A. (2000) Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191, 813-822.
3. Lee, D. M., Friend, D. S., Gurish, M. F., Benoist, C., Mathis, D., Brenner, M. B. (2002) Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297, 1689-1692.
4. Hara, M., Ono, K., Hwang, M., Iwasaki, A., Okada, M., Nakatani, K., Sasayama, S., Matsumori, A. (2002) Evidence for a role of mast cells in the evolution to congestive heart failure. J. Exp. Med. 195, 375-381.
5. Ryan, J., Huff, T. F. 2003. Biology of mast cells. In Allergy: Principles and Practices, St. Louis, MO, Mosby, 333-346.
6. Bailey, D. P., Kashyap, M., Mirmonsef, P., Bouton, L., Domen, J., Zhu, J., Dessypris, E., Ryan, J. J. (2004) Interleukin-4 elicits apoptosis of developing mast cells via a Stat6-dependent mitochondrial pathway. Exp. Hematol. 32, 52-59.
7. Fiorentino, D. F., Bond, M. W., Mosmann, T. R. (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170, 2081-2095.
8. Moore, K. W., de Waal Malefyt, R., Coffman, R. L., O'Garra, A. (2001) Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765.
9. Gillespie, S. R., DeMartino, R., Zhu, J., Chong, H., Ramirez, C., Shelburne, C., Bouton, L., Bailey, D., Gharse, A., Mirmonsef, P., Odom, S., Gomez, G., Rivera, J., Fischer-Stenger, K., Ryan, J. J. (2004) Interleukin-10 inhibits Fc ε receptor I expression in mouse mast cells. J. Immunol. 172, 3181-3188.
10. Mirmonsef, P., Shelburne, C. P., Fitzhugh Yeatman II, C., Chong, H. J., Ryan, J. J. (1999) Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3′ kinase. J. Immunol. 163, 2530-2539.
11. Yeatman, C. F., Jacobs-Helbers, S., Mirmonsef, P., Gillespie, S., Bouton, L., Collins, H., Sawyer, S., Shelburne, C., Ryan, J. J. (2000) Combined stimulation twith the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis. J. Exp. Med. 192, 1093-1104.
12. Bouton, L. A., Ramirez, C. D., Bailey, D. P., Yeatman, C., Yue, J., Wright, H., Domen, J., Rosato, R., Grant, S., Fischer-Stenger, K., Ryan, J. J. (2004) Co-stimulation with interleukin-4 and interleukin-10 induces mast cell apoptosis and cell cycle arrest: the role of p53 and the mitochondrion. Exp. Hematol. 32, 1137-1145.
13. Takeda, K., Clausen, B., Kaisho, T., Tsujimura, T., Terada, N., Forster, I., Akira, S. (1999) Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of STAT3 in macrophages and neutrophils. Immunity 10, 39-49.
14. Riley, J. K., Takeda, K., Akira, S., Schreiber, R. (1999) Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinict receptor-derived signals for anti-inflammatory action. J. Biol. Chem. 274, 16513-16521.
15. O'Farrell, A. M., Liu, Y., Moore, K. W., Mui, A. L. (1998) IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for STAT3-dependent and -independent pathways. EMBO J. 17, 1006-1018.
16. O'Farrel, A. M., Parry, D. A., Zindy, F., Roussel, M. F., Lees, E., Moore, K., Mui, A. (2000) STAT3-dependent induction of p19ink4D by IL-10 contributes to inhibition of macrophage proliferation. J. Immunol. 164, 4607-4615.
17. Weber-Nordt, R. M., Riley, J. K., Greenlund, A. C., Moore, K. W., Darnell, J. E., Schreiber, R. D. (1996) STAT3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J. Biol. Chem. 271, 27954-27961.
18. Calo, V., Migliavacca, M., Bazan, V., Macaluso, M., Buscemi, M., Gebbia, N., Russo, A. (2003) STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 197, 157-168.
19. Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kisihimoto, T., Akira, S. (1997) Targeted disruption of the mouse STAT3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94, 3801-3804.
20. Lang, R., Patal, D., Morris, J. J., Rutschman, R. L., Murray, P. J. (2002) Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 169, 2253-2263.
21. Domen, J., Gandy, K., Weissman, I. L. (1998) Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 91, 2272-2282.
22. Green, D. R., Reed, J. C. (1998) Mitochondria and apoptosis. Science 281, 1309-1312.
23. Sionov, R. V., Haupt, Y. (1999) The cellular response to p53: the decision between life and death. Oncogene 18, 6145-6157.
24. Cua, D. J., Hutchins, B., LaFace, D. M., Stohlman, S. A., Coffman, R. L. (2001) Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 166, 602-608.
25. Cua, D. J., Groux, H., Hinton, D. R., Stohlman, S. A., Coffman, R. L. (1999) Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 189, 1005-1010.
26. Mathisen, P. M., Yu, M., Johnson, J. M., Drazba, J. A., Tuohy, V. K. (1997) Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med. 186, 159-164.
27. Zheng, X. X., Steele, A. W., Hancock, W. W., Stevens, A., Nickerson, P., Roy-Chaudhury, P., Tian, Y., Strom, T. (1997) A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J. Immunol. 158, 4507-4513.
28. Kasama, T., Strieter, R. M., Lukacs, N. W., Lincoln, P., Burdick, M., Kunkel, S. (1995) Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin. Invest. 95, 2868-2876.
29. Persson, S., Mikulowska, A., Narula, S., O'Garra, A., Holmdahl, R. (1996) Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand. J. Immunol. 44, 607-614.
30. Tanaka, Y., Otsuka, T., Hotokebuchi, T., Miyahara, H., Nakashima, H., Kuga, S., Nemoto, Y., Niiro, H., Niho, Y. (1996) Effect of IL-10 on collagen-induced arthritis in mice. Inflamm. Res. 45, 283-288.
31. van Roon, J. A., van Roy, J. L., Gmelig-Meyling, F. H., Lafeber, F. P., Bijlsma, J. W. (1996) Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum. 39, 829-835.
32. Walmsley, M., Katsikis, P. D., Abney, E., Parry, S., Williams, R., Maini, R., Feldmann, M. (1996) Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. 39, 495-503.
33. Whalen, J. D., Lechman, E. L., Carlos, C. A., Weiss, K., Kovesdi, I., Glorioso, J., Robbins, P., Evans, C. (1999) Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J. Immunol. 162, 3625-3632.
34. Joosten, L. A., Lubberts, E., Durez, P., Helsen, M., Jacobs, M., Goldman, M., van den Berg, W. (1997) Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40, 249-260.
35. Justice, J. P., Shibata, Y., Sur, S., Mustafa, J., Fan, M., Van Scott, M. R. (2001) IL-10 gene knockout attenuates allergen-induced airway hyper-responsiveness in C57BL/6 mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L363-L368.
36. Kucharzik, T., Stoll, R., Lugering, N., Domschke, W. (1995) Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 100, 452-456.
37. Schreiber, S., Heinig, T., Thiele, H. G., Raedler, A. (1995) Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 108, 1434-1444.
38. Marchant, A., Deviere, J., Byl, B., De Groote, D., Vincent, J. L., Goldman, M. (1994) Interleukin-10 production during septicaemia. Lancet 343, 707-708.
39. Marchant, A., Alegre, M. L., Hakim, A., Pierard, G., Marecaux, G., Friedman, G., De Groote, D., Kahn, R., Vincent, J., Goldman, M. (1995) Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J. Clin. Immunol. 15, 266-273.
40. O'Hara, R. J., Greenman, J., MacDonald, A. W., Duthie, G., Lee, P., Monson, J. (1998) Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin. Cancer Res. 4, 1943-1948.
41. Kozlowski, L., Zakrzewska, I., Tokajuk, P., Wojtukiewicz, M. Z. (2003) Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Rocz. Akad. Med. Bialymst. 48, 82-84.
42. Lech-Maranda, E., Baseggio, L., Bienvenu, J., Charlot, C., Berger, F., Rigal, D., Warzocha, K., Coiffier, B., Salles, G. (2004) The interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 103, 3529-3534.
43. Hattori, E., Okumoto, K., Adachi, T., Takeda, T., Ito, J., Sugahara, K., Watanabe, H., Saito, K., Saito, T., Togashi, H., Kawata, S. (2003) Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma. Hepatol. Res. 27, 309-314.
44. Reiser, M., Marousis, C. G., Nelson, D. R., Lauer, G., Gonzalez-Peralta, R., Davis, G., Lau, J. (1997) Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J. Hepatol. 26, 471-478.
45. Tziakas, D. N., Chalikias, G. K., Hatzinikolaou, H. I., Parissis, J., Papadopoulos, E., Trypsianis, G., Papadopoulou, E., Tentes, I., Kara, S., Hatseras, D. (2003) Anti-inflammatory cytokine profile in acute coronary syndromes: behavior of interleukin-10 in association with serum metalloproteinases and proinflammatory cytokines. Int. J. Cardiol. 92, 169-175.
46. Hussain, M. J., Peakman, M., Gallati, H., Lo, S., Hawa, M., Viberti, G., Watkins, P., Leslie, R., Vergani, D. (1996) Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39, 60-69.
47. Hasegawa, M., Fujimoto, M., Kikuchi, K., Takehara, K. (1997) Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J. Rheumatol. 24, 328-332.
48. Rennick, D., Hunte, B., Dang, W., Thompson-Snipes, L., Hudak, S. (1994) Interleukin-10 promotes the growth of megakaryocyte, mast cell, and multilineage colonies: analysis with committed progenitors and Thy1loSca1+ stem cells. Exp. Hematol. 22, 136-141.
49. Rennick, D., Hunte, B., Holland, G., Thompson-Snipes, L. (1995) Cofactors are essential for stem cell factor-dependent growth and maturation of mast cell progenitors: comparative effects of interleukin-1 (IL-3), IL-4, IL-10, and fibroblasts. Blood 85, 57-65.
50. Thompson -Snipes, L., Dhar, V., Bond, M. W., Mosmann, T. R., Moore, K. W., Rennick, D. M. (1991) Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173, 507-510.
51. Lantz, C. S., Huff, T. F. (1995) Murine KIT+ lineage-bone marrow progenitors express Fc γ-RII but do not express Fc ε-RI until mast cell granule formation. J. Immunol. 154, 355-362.
52. Bojes, H. K., Feng, X., Kehrer, J. P., Cohen, G. M. (1999) Apoptosis in hematopoietic cells (FL5.12) caused by interleukin-3 withdrawal: relationship to caspase activity and loss of glutathione. Cell Death Differ. 6, 61-70.
53. Ryan, J. J., DeSimone, S., Klisch, G., Shelburne, C., McReynolds, L. J., Han, K., Kovacs, R., Mirmonsef, P., Huff, T. F. (1998) IL-4 inhibits mouse mast cell Fc εRI expression through a STAT6-dependent mechanism. J. Immunol. 161, 6915-6923.
54. Suzuki, I., Hizawa, N., Yamaguchi, E., Kawakami, Y. (2000) Association between a C+33T polymorphism in the IL-4 promoter region and total serum IgE levels. Clin. Exp. Allergy 30, 1746-1749.
55. Takabayashi, A., Ihara, K., Sasaki, Y., Suzuki, Y., Nishima, S., Izuhara, K., Hamasaki, N., Hara, T. (2000) Childhood atopic asthma: positive association with a polymorphism of IL-4 receptor α gene but not with that of IL-4 promoter or Fc β receptor I β gene. Exp. Clin. Immunogenet. 17, 63-70.
56. Hershey, G. K., Friedrich, M. F., Esswein, L. A., Thomas, M. L., Chatila, T. A. (1997) The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor. N. Engl. J. Med. 337, 1720-1725.
57. Gao, P. S., Mao, X. Q., Hopkin, J. M., Adra, C. N., Yang, X., Shirakawa, T. (2000) Functional significance of polymorphisms of the interleukin-4 and interleukin-13 receptors in allergic disease. Clin. Exp. Allergy 30, 1672-1675.
58. Hobbs, K., Negri, J., Klinnert, M., Rosenwasser, L. J., Borish, L. (1998) Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma. Am. J. Respir. Crit. Care Med. 158, 1958-1962.